Tempus AI (NASDAQ:TEM) Stock Price Up 2.6% - Should You Buy?

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) shares traded up 2.6% on Monday . The company traded as high as $59.08 and last traded at $58.35. 2,676,169 shares traded hands during trading, a decline of 64% from the average session volume of 7,528,381 shares. The stock had previously closed at $56.88.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Bank of America lifted their price objective on shares of Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a report on Wednesday, June 25th. Morgan Stanley lifted their price objective on shares of Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. Guggenheim boosted their target price on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research report on Monday, June 30th. Needham & Company LLC restated a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a research note on Wednesday, May 7th. Finally, Piper Sandler boosted their target price on shares of Tempus AI from $55.00 to $70.00 and gave the company a "neutral" rating in a research note on Thursday, May 15th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $65.09.

Tempus AI Trading Up 3.1%

The company has a current ratio of 1.71, a quick ratio of 1.56 and a debt-to-equity ratio of 2.45. The business's 50-day simple moving average is $62.98 and its two-hundred day simple moving average is $55.08. The company has a market capitalization of $10.15 billion and a PE ratio of -7.52.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.03. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The company had revenue of $255.74 million during the quarter, compared to the consensus estimate of $248.13 million. The firm's revenue was up 75.4% on a year-over-year basis. On average, analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Insider Buying and Selling at Tempus AI

In related news, EVP Erik Phelps sold 51,317 shares of the stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $72.56, for a total value of $3,723,561.52. Following the completion of the transaction, the executive vice president owned 97,779 shares of the company's stock, valued at $7,094,844.24. This represents a 34.42% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Ryan Fukushima sold 20,000 shares of the company's stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $52.36, for a total transaction of $1,047,200.00. Following the sale, the chief operating officer directly owned 884,460 shares in the company, valued at $46,310,325.60. This represents a 2.21% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 612,522 shares of company stock worth $41,600,238 over the last 90 days. 27.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Tempus AI

Several hedge funds have recently bought and sold shares of TEM. Bank of New York Mellon Corp bought a new stake in shares of Tempus AI during the 4th quarter worth about $1,615,000. US Bancorp DE acquired a new position in Tempus AI during the 4th quarter worth approximately $80,000. Victory Capital Management Inc. acquired a new position in Tempus AI during the 4th quarter worth approximately $216,000. Raymond James Financial Inc. bought a new stake in Tempus AI during the 4th quarter worth approximately $3,757,000. Finally, Farther Finance Advisors LLC bought a new stake in Tempus AI during the 4th quarter worth approximately $34,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.